Medicina (B.Aires); 82 (4), 2022

Immunoglobulin light chain (AL) amyloidosis is a rare disease. Treatment is challenging, justified in part by systemic compromise and limited scientific evidence. Develop evidencebased recommendations that allow adequate treatment of patients with amyloidosis AL. A list of PICO format questions focused ...

Fulltext

Chronic lymphocytic leukemia is a disease with an extremely diverse clinical course. It is a disease of older people, the median age of the patient at the time of diagnosis is between 65-70 years. CLL is the most common leukemia in the Western world, accounting for over 30% of all cases of the disease. I...

Fulltext